Peloton Therapeutics, Inc. Stock
Equities
PLTX
US70614L1044
Biotechnology & Medical Research
Managers | Title | Age | Since |
---|---|---|---|
Naseem Zojwalla
CTO | Chief Tech/Sci/R&D Officer | 51 | - |
Corporate Officer/Principal | - | - | |
Peter Stenge
PRN | Corporate Officer/Principal | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Helen Kim
BRD | Director/Board Member | 61 | 17-10-31 |
Brett A. Ringle
BRD | Director/Board Member | 73 | 10-12-31 |
David Chang
BRD | Director/Board Member | 64 | 18-01-31 |
1st Jan change | Capi. | |
---|---|---|
-2.26% | 103B | |
+1.41% | 95.71B | |
+0.23% | 22.02B | |
-17.84% | 20.9B | |
-9.12% | 17.85B | |
-42.83% | 16.21B | |
-17.63% | 15.52B | |
+4.55% | 13.86B | |
+32.11% | 12.04B |